Trial Profile

Compare the Efficacy of Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ticagrelor (Primary) ; Aspirin
Indications Thrombosis
Focus Adverse reactions; Therapeutic Use
Acronyms DACAB

Most Recent Events

10 Mar 2020 Results of substudy of DACAB (DACAB-GI-1) assessing upper gastrointestinal mucosal injury and use of proton pump inhibitors in patients receiving 1 year of antiplatelet therapy after coronary artery bypass grafting published in the Journal of Gastroenterology and Hepatology
02 Jan 2020 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com